Bridgewater Associates - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.

Quarter-by-quarter ownership
Bridgewater Associates ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$640,000
-30.4%
4,232
-32.9%
0.00%
-25.0%
Q2 2022$919,000
+31.3%
6,308
+6.9%
0.00%
+33.3%
Q1 2022$700,000
+23.2%
5,900
+43.3%
0.00%0.0%
Q4 2021$568,0004,1180.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 490,422$12,755,87613.24%
FNY Investment Advisers, LLC 30$00.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders